Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
- 3 August 2020
- journal article
- research article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 26 (1) , 165-171
Abstract
Patients with heart failure with preserved ejection fraction (HFpEF) are often elderly and likely to have cardiac comorbidities such as coronary artery disease (CAD) and atrial fibrillation (AF). The primary chronic symptom of HFpEF patients is severe exercise intolerance. The inability to adequately increase heart rate during exercise is commonly present in HFpEF patients and contributes to their exercise intolerance. Although beta-blockers are frequently used for the treatment of myocardial ischemia and tachycardia in HFpEF patients, there is a concern that slowing heart rate by beta-blockers may worsen chronotropic incompetence and further exacerbate their symptoms. Although the effect of beta-blockers on heart failure severity in HFpEF patients has been examined in randomized controlled trials (RCTs), results are inconsistent due partly to limited power. We aimed to conduct a meta-analysis of RCTs on the effect of beta-blockers on heart failure severity in HFpEF patients. The search of electronic databases identified 5 RCTs including 538 patients. In pooled analyses, beta-blockers did not significantly change the New York Heart Association (NYHA) class, exercise capacity expressed as metabolic equivalents, or plasma B-type natriuretic peptide (BNP) levels compared with control but with substantial heterogeneity across trials. In meta-regression analyses, the higher proportion of CAD or AF in the included trials was associated with a decrease in NYHA class and BNP levels and with an increase in exercise capacity. Thus, we found no clear beneficial effect of beta-blockers on heart failure severity in HFpEF patients. However, beta-blockers may be beneficial in HFpEF patients with CAD or AF.Keywords
This publication has 25 references indexed in Scilit:
- Effects of the Long-Term Administration of Nebivolol on the Clinical Symptoms, Exercise Capacity, and Left Ventricular Function of Patients with Diastolic Dysfunction: Results of the ELANDD StudyEuropean Journal of Heart Failure, 2012
- Abnormal Haemodynamic Response to Exercise in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2011
- Characteristics and Outcomes of Hospitalized Patients With Heart Failure and Reduced vs Preserved Ejection Fraction A Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)Circulation Journal, 2009
- Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fractionThe American Journal of Cardiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part IICirculation, 2002
- New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part ICirculation, 2002
- Congestive heart failure in subjects with normal versus reduced left ventricular ejection fractionJACC, 1999
- Variance imputation for overviews of clinical trials with continuous responseJournal of Clinical Epidemiology, 1992
- The role of nitrates, beta blockers, and calcium antagonists in stable angina pectorisAmerican Heart Journal, 1988